Latest news
Loading news…
Linnaeus Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Haddonfield, New Jersey, United States Founded 2016 1-10 employees For Profit
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
5
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 24
- Patents granted
- 5
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $73K
Company Info
- Founded
- 2016
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 23
- HQ
- Haddonfield, New Jersey, United States
- Region
- Greater Philadelphia Area, East Coast, Northeastern US
Signals & Scores
- Heat score
- Medium
- Growth score
- High
- Trend (7d)
- -0.3
- Trend (30d)
- 1
- Trend (90d)
- -2.5
Key People at Linnaeus Therapeutics
Co-Founder & VP of Research
CEO
Co-founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Linnaeus Therapeutics
Loading news…
FAQs about Linnaeus Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.